High DRD2 protein expression on tumour cells was observed in 48% of pheochromocytomas, and DRD1 expression ranged from 14% in melanoma to 57% in renal cell carcinoma. This evidence concerns the gene DRD2 and hereditary pheochromocytoma-paraganglioma.